Latest Breaking News On - French study group of cutaneous lymphoma - Page 1 : comparemela.com

Kyowa Kirin Co Ltd: Kyowa Kirin Demonstrates Commitment to Real-world Evidence for POTELIGEO (mogamulizumab) at EORTC 2023

Kyowa Kirin Co Ltd: Kyowa Kirin Demonstrates Commitment to Real-world Evidence for POTELIGEO (mogamulizumab) at EORTC 2023
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United kingdomUnited statesBaden wübergPablo ortiz romeroMarie beylot barryChalid assafKlinikum krefeldJulia scarisbrickStacey mintonTreatment of cancer cutaneous lymphoma tumour groupWorld international observational study of mogamulizumabKyowa kirin co ltdBordeaux institute of oncologyEuropean organisation for researchUniversity hospital birminghamKyowa kirin international

Kyowa Kirin Demonstrates Commitment to Real-world Evidence for POTELIGEO® (mogamulizumab) at EORTC 2023

TOKYO, September 21, 2023 Kyowa Kirin International (KKI), a wholly owned subsidiary of Kyowa Kirin Co. Ltd, today announced the acceptance of an extensive programme of data to the annual meeting of the European Organisation for Research and Treatment of Cancer’s Cutaneous Lymphoma Tumour Group (EORTC-CLTG), taking place from the 21st – 23rd of September 2023 in Leiden, the Netherlands.

United statesUnited kingdomKlinikum krefeldStacey mintonPablo ortiz romeroMarie beylot barryChalid assafJulia scarisbrickKyowa kirin internationalTreatment of cancer cutaneous lymphoma tumour groupKyowa kirin co ltdFrench study group of cutaneous lymphomaBordeaux institute of oncologyEuropean organisation for researchUniversity hospital birminghamInternational medical affairs